Evaluation of the Glycemic Index in 4 Dairy Beverages.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05204823

Acronym

Enrollment

Registered

2022-01-24

Start date

2021-12-06

Completion date

2022-05-16

Last updated

2022-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycemic Index, Cognitive Performance

Brief summary

The objective of the study is to evaluate the glycemic index and glycemic load of 4 chocolate milk drinks.

Detailed description

Subjects will make a total of 5 visits. Four visits where they will drink a chocolate milkshake at each visit. In the other visit they will take glucose, as a comparator product. Due to the low amount of sugars in the shakes, subjects will drink the equivalent of 25g of glucose. At each visit subjects will have to come fasting, and samples will be collected at 9 different times.

Interventions

OTHERExperimental product

Chocolate milk shakes

OTHERControl product

Glucose

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

OTHER

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* Subjects of both sexes (10 men and 10 women). * Subjects aged between 20 and 35 years. * Subjects with a body mass index between 20 and 25 kg/m2.

Exclusion criteria

* Subjects suffering from diabetes mellitus or any chronic disease. * Subjects with medical problems or a diagnosed psychiatric disorder. * Subjects with alcohol abuse or excessive alcohol consumption (\>3 glasses of wine or beer/day). * Subjects consuming any pharmacological medication that may affect memory. * Participation in another clinical trial in the three months prior to the study. * Unwillingness or inability to comply with clinical trial procedures. * Subjects whose condition does not make them eligible for the study according to the investigator's criteria. * Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame	Description
Glucose	The glucose evolution will be measured for 210 minutes after product consumption.	It will be evaluated by means of a glucometer.

Secondary

Measure	Time frame	Description
Glucose	Each product will be measured at 15, 30, 45, 60, 90, 120 and 150 minutes after consumption.	It will be evaluated by means of a glucometer.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026